PMID- 37905154 OWN - NLM STAT- PubMed-not-MEDLINE LR - 20240210 DP - 2023 Oct 16 TI - Blocking Formation of Neurotoxic Reactive Astrocytes is Beneficial Following Stroke. LID - 2023.10.11.561918 [pii] LID - 10.1101/2023.10.11.561918 [doi] AB - Microglia and astrocytes play an important role in the neuroinflammatory response and contribute to both the destruction of neighboring tissue as well as the resolution of inflammation following stroke. These reactive glial cells are highly heterogeneous at both the transcriptomic and functional level. Depending upon the stimulus, microglia and astrocytes mount a complex, and specific response composed of distinct microglial and astrocyte substates. These substates ultimately drive the landscape of the initiation and recovery from the adverse stimulus. In one state, inflammation- and damage-induced microglia release tumor necrosis factor (TNF), interleukin 1alpha (IL1alpha), and complement component 1q (C1q), together 'TIC'. This cocktail of cytokines drives astrocytes into a neurotoxic reactive astrocyte (nRA) substate. This nRA substate is associated with loss of many physiological astrocyte functions (e.g., synapse formation and maturation, phagocytosis, among others), as well as a gain-of-function release of neurotoxic long-chain fatty acids which kill neighboring cells. Here we report that transgenic removal of TIC led to reduction of gliosis, infarct expansion, and worsened functional deficits in the acute and delayed stages following stroke. Our results suggest that TIC cytokines, and likely nRAs play an important role that may maintain neuroinflammation and inhibit functional motor recovery after ischemic stroke. This is the first report that this paradigm is relevant in stroke and that therapies against nRAs may be a novel means to treat patients. Since nRAs are evolutionarily conserved from rodents to humans and present in multiple neurodegenerative diseases and injuries, further identification of mechanistic role of nRAs will lead to a better understanding of the neuroinflammatory response and the development of new therapies. FAU - Prescott, Kimberly AU - Prescott K AUID- ORCID: 0000-0002-4652-6724 AD - Department of Psychology, University of North Carolina Wilmington, 28428. FAU - Munch, Alexandra E AU - Munch AE AUID- ORCID: 0000-0002-9609-3277 AD - Neuroscience Department, Stanford University, 94035. FAU - Brahms, Evan AU - Brahms E AUID- ORCID: 0000-0002-0073-3699 AD - Department of Neurology and Neurological Sciences, Stanford School of Medicine, 94305. FAU - Weigel, Maya M AU - Weigel MM AUID- ORCID: 0000-0003-0557-5172 AD - Neuroscience Department, Stanford University, 94035. FAU - Inoue, Kenya AU - Inoue K AUID- ORCID: 0009-0004-0760-5341 AD - Department of Psychology, University of North Carolina Wilmington, 28428. FAU - Buckwalter, Marion S AU - Buckwalter MS AUID- ORCID: 0000-0003-2807-2447 AD - Department of Neurology and Neurological Sciences, Stanford School of Medicine, 94305. AD - Department of Neurosurgery, Stanford School of Medicine, 94305. FAU - Liddelow, Shane A AU - Liddelow SA AUID- ORCID: 0000-0002-0840-1437 AD - Neuroscience Institute, NYU Grossman School of Medicine, 10016. AD - Department of Neuroscience and Physiology, NYU Grossman School of Medicine, 10016. AD - Department of Ophthalmology, NYU Grossman School of Medicine, 10016. AD - Parekh Center for Interdisciplinary Neurology, NYU Grossman School of Medicine, 10016. FAU - Peterson, Todd C AU - Peterson TC AUID- ORCID: 0000-0001-5441-6157 AD - Department of Psychology, University of North Carolina Wilmington, 28428. AD - Department of Neurology and Neurological Sciences, Stanford School of Medicine, 94305. LA - eng GR - F32 NS089162/NS/NINDS NIH HHS/United States GR - R01 EY033353/EY/NEI NIH HHS/United States PT - Preprint DEP - 20231016 PL - United States TA - bioRxiv JT - bioRxiv : the preprint server for biology JID - 101680187 PMC - PMC10614742 COIS- Conflict of interest statement: SAL declares ownership in AstronauTx Ltd, and sits on the Scientific Advisory Board of the Global BioAccess Fund, Tamborine, and Synapticure. The other authors declare no competing financial interests. EDAT- 2023/10/31 06:42 MHDA- 2023/10/31 06:43 PMCR- 2023/10/30 CRDT- 2023/10/31 04:03 PHST- 2023/10/31 06:42 [pubmed] PHST- 2023/10/31 06:43 [medline] PHST- 2023/10/31 04:03 [entrez] PHST- 2023/10/30 00:00 [pmc-release] AID - 2023.10.11.561918 [pii] AID - 10.1101/2023.10.11.561918 [doi] PST - epublish SO - bioRxiv [Preprint]. 2023 Oct 16:2023.10.11.561918. doi: 10.1101/2023.10.11.561918.